| __timestamp | Amphastar Pharmaceuticals, Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 79696000 |
| Thursday, January 1, 2015 | 37065000 | 93236000 |
| Friday, January 1, 2016 | 41199000 | 150842000 |
| Sunday, January 1, 2017 | 43415000 | 150643000 |
| Monday, January 1, 2018 | 57564000 | 150252000 |
| Tuesday, January 1, 2019 | 68853000 | 140804000 |
| Wednesday, January 1, 2020 | 67229000 | 34236000 |
| Friday, January 1, 2021 | 60932000 | 35672000 |
| Saturday, January 1, 2022 | 74771000 | 66607000 |
| Sunday, January 1, 2023 | 73741000 | 76363000 |
| Monday, January 1, 2024 | 79048000 |
Igniting the spark of knowledge
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Halozyme Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc. have demonstrated distinct trajectories in their R&D investments. From 2014 to 2023, Halozyme consistently allocated a significant portion of its resources to R&D, peaking in 2016 with expenditures nearly doubling those of Amphastar. However, a notable decline occurred in 2020, with expenses dropping by over 75% from the previous year. In contrast, Amphastar's R&D spending showed a steady upward trend, culminating in a 160% increase by 2022 compared to 2014. This divergence highlights the strategic differences between the two companies, with Halozyme focusing on breakthrough innovations and Amphastar steadily enhancing its existing product lines. As the industry continues to evolve, these R&D investments will play a crucial role in shaping the future of healthcare.
Pfizer Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Investment: Gilead Sciences, Inc. vs Halozyme Therapeutics, Inc.
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Investment: Jazz Pharmaceuticals plc vs Halozyme Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Corcept Therapeutics Incorporated
R&D Spending Showdown: Halozyme Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.
R&D Spending Showdown: Veracyte, Inc. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Xenon Pharmaceuticals Inc. vs Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Wave Life Sciences Ltd. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amphastar Pharmaceuticals, Inc. vs Novavax, Inc.